Nicole Vitullo, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 346 shares at $5.34 ($2K) on 2013-03-11, disclosed to the SEC on 2013-03-13.
Scheduled sale ($2k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.34 | 136 | $726 | 39.1% |
| 2 | $5.38 | 210 | $1K | 60.9% |
| Total | $5.36 avg | 346 | $2K | 100% |
| Filing → |
| ESPR | SELL | 2018-01-26 | $1.7M | — | Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |